142 related articles for article (PubMed ID: 1309006)
1. The molecular basis of glucocorticoid-remediable aldosteronism, a Mendelian cause of human hypertension.
Lifton RP; Dluhy RG; Powers M; Ulick S; Lalouel JM
Trans Assoc Am Physicians; 1992; 105():64-71. PubMed ID: 1309006
[No Abstract] [Full Text] [Related]
2. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.
Lifton RP; Dluhy RG; Powers M; Rich GM; Cook S; Ulick S; Lalouel JM
Nature; 1992 Jan; 355(6357):262-5. PubMed ID: 1731223
[TBL] [Abstract][Full Text] [Related]
3. Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.
Lifton RP; Dluhy RG; Powers M; Rich GM; Gutkin M; Fallo F; Gill JR; Feld L; Ganguly A; Laidlaw JC
Nat Genet; 1992 Sep; 2(1):66-74. PubMed ID: 1303253
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid-remediable aldosteronism.
Halperin F; Dluhy RG
Endocrinol Metab Clin North Am; 2011 Jun; 40(2):333-41, viii. PubMed ID: 21565670
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoid-remediable aldosteronism.
Dluhy RG; Williams GH
Cardiovasc Res; 1996 Jun; 31(6):870-2. PubMed ID: 8759241
[No Abstract] [Full Text] [Related]
6. Glucocorticoid-remediable aldosteronism.
Dluhy RG; Lifton RP
Endocrinol Metab Clin North Am; 1994 Jun; 23(2):285-97. PubMed ID: 8070423
[TBL] [Abstract][Full Text] [Related]
7. Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.
Fallo F; Pilon C; Williams TA; Sonino N; Morra Di Cella S; Veglio F; De Iasio R; Montanari P; Mulatero P
J Hum Hypertens; 2004 Jan; 18(1):47-51. PubMed ID: 14688810
[TBL] [Abstract][Full Text] [Related]
8. Genetic screening for glucocorticoid-remediable aldosteronism (GRA): experience of three clinical centres in Poland.
Adler G; Widecka K; Peczkowska M; Dobrucki T; Placha G; Drozd R; Parczewski M; Januszewicz A; Gaciong Z; Ciechanowicz A
J Appl Genet; 2005; 46(3):329-32. PubMed ID: 16110193
[TBL] [Abstract][Full Text] [Related]
9. A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism.
Geller DS; Zhang J; Wisgerhof MV; Shackleton C; Kashgarian M; Lifton RP
J Clin Endocrinol Metab; 2008 Aug; 93(8):3117-23. PubMed ID: 18505761
[TBL] [Abstract][Full Text] [Related]
10. [Glucocorticoid remediable aldosteronism].
Omura M; Nishikawa T
Nihon Rinsho; 2006 May; Suppl 1():628-34. PubMed ID: 16776234
[No Abstract] [Full Text] [Related]
11. A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension.
Jonsson JR; Klemm SA; Tunny TJ; Stowasser M; Gordon RD
Biochem Biophys Res Commun; 1995 Feb; 207(2):565-71. PubMed ID: 7864844
[TBL] [Abstract][Full Text] [Related]
12. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree.
Pascoe L; Jeunemaitre X; Lebrethon MC; Curnow KM; Gomez-Sanchez CE; Gasc JM; Saez JM; Corvol P
J Clin Invest; 1995 Nov; 96(5):2236-46. PubMed ID: 7593610
[TBL] [Abstract][Full Text] [Related]
13. Glucocorticoid-remediable aldosteronism.
McMahon GT; Dluhy RG
Cardiol Rev; 2004; 12(1):44-8. PubMed ID: 14667264
[TBL] [Abstract][Full Text] [Related]
14. The chimeric gene linked to glucocorticoid-suppressible hyperaldosteronism encodes a fused P-450 protein possessing aldosterone synthase activity.
Miyahara K; Kawamoto T; Mitsuuchi Y; Toda K; Imura H; Gordon RD; Shizuta Y
Biochem Biophys Res Commun; 1992 Dec; 189(2):885-91. PubMed ID: 1472060
[TBL] [Abstract][Full Text] [Related]
15. Dissecting hypertension: the role of the 'new genetics'.
Jamieson A
J R Coll Physicians Lond; 1994; 28(6):512-8. PubMed ID: 7884706
[TBL] [Abstract][Full Text] [Related]
16. Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications.
Carroll J; Dluhy R; Fallo F; Pistorello M; Bradwin G; Gomez-Sanchez CE; Mortensen R
J Clin Endocrinol Metab; 1996 Dec; 81(12):4310-2. PubMed ID: 8954032
[TBL] [Abstract][Full Text] [Related]
17. [Hypertension secondary to adrenal steroidogenic enzyme deficiency].
Yanase T
Nihon Rinsho; 2004 Mar; 62 Suppl 3():531-5. PubMed ID: 15171430
[No Abstract] [Full Text] [Related]
18. Mutation analysis of CYP11B1 and CYP11B2 in patients with increased 18-hydroxycortisol production.
Nicod J; Dick B; Frey FJ; Ferrari P
Mol Cell Endocrinol; 2004 Feb; 214(1-2):167-74. PubMed ID: 15062555
[TBL] [Abstract][Full Text] [Related]
19. Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism.
Lee IS; Kim SY; Jang HW; Kim MK; Lee JH; Lee YH; Jo YS
J Korean Med Sci; 2010 Sep; 25(9):1379-83. PubMed ID: 20808686
[TBL] [Abstract][Full Text] [Related]
20. Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.
Pascoe L; Curnow KM; Slutsker L; Connell JM; Speiser PW; New MI; White PC
Proc Natl Acad Sci U S A; 1992 Sep; 89(17):8327-31. PubMed ID: 1518866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
